Pfizer Raises Sales Forecast for COVID-19 Biologic to $33.5 Billion in 2021
Pfizer, Inc. reported that the company sold $7.8 billion worth of their COVID-19 biologic BNT162b2 in the second quarter of this year raising the company’s 2021 sales forecast for the two-dose vaccine to $33.5 billion from the previously estimated $26 billion.1 The $7.8 billion from direct sales of the shot is split with its German […]
Existing Drugs Hold Promise for Treatment of COVID-19
Story Highlights A group of Israeli researchers have studied close to 3,000 approved drugs to see if any could be repurposed to treat COVID-19. They identified 18 that showed encouraging results in laboratory studies, in many cases completely protecting human cells despite infection with SARS-CoV-2, the virus that causes COVID-19. Three drugs have been singled […]
Johnson & Johnson Recalls Carcinogen Containing Sunscreen Products
On July 14, 2021, Johnson and Johnson Consumer, Inc. voluntarily recalled all batches of five NEUTROGENA and AVEENO aerosol sunscreen product lines distributed to consumers through a variety of retail channels. The corporation recalled the products after a cancer causing chemical known as benzene was detected in samples. The products were distributed nationwide and Johnson […]
75 Percent COVID-19 Vaccination Rate Among U.S. Hospital Workers
An analysis conducted by WebMD and Medscape Medical News from data collected by the U.S. Department of Health and Human Services (HHS) from 2,500 hospitals across the United States revealed that, as of late May 2021, one in four hospital workers caring for patients had not received a COVID-19 vaccination.1 Many Hospital Workers Are Refusing […]
Former FDA Chief Stephen Hahn Joins Venture Capital Firm Behind Moderna COVID Vaccine
Stephen Hahn, MD, who served as commissioner of the U.S. Food and Drug Administration (FDA) from Dec. 17, 2019 through Jan. 20, 2021, has been hired by Flagship Pioneering Co.—the venture capital firm that launched biotechnology Moderna, Inc., maker of the experimental mRNA-1273 COVID-19 biologic currently being distributed in the United States under an emergency […]
40 Percent of U.S. Marines Opting Out of COVID-19 Vaccination
Story Highlights Among U.S. military forces, the rate of refusal for the experimental COVID-19 vaccines is reportedly at about 33 percent but may be higher. A new report shows that the number of Marines declining COVID-19 vaccinations may be closer to 40 percent. To date, the military cannot mandate COVID-19 vaccinations because the FDA only […]
